Hamid Khoja
Net worth: 3 553 $ as of 2026-05-30
Net worth: 3 553 $ as of 2026-05-30
Hamid Khoja is currently Chief Scientific Officer at FibroBiologics, Inc. since 2021.
Formerly, worked as Principal Scientist at Covaris LLC from 2009 to 2021, and as Scientist at Chiron Corp.
and Eli Lilly & Co. Education includes a doctorate from Boston University and an undergraduate degree from the University of Southern California.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
FIBROBIOLOGICS, INC. 0.06% | 2026-05-03 | 3,063 ( 0.06% ) | 3 553 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| FIBROBIOLOGICS, INC. | Chief Tech/Sci/R&D Officer | 2021-07-31 |
| Companies | Position | End |
|---|---|---|
Covaris LLC
Covaris LLC Medical SpecialtiesHealth Technology Develops, manufactures and markets instruments, consumables & reagents | Corporate Officer/Principal | 2021-07-31 |
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Chief Tech/Sci/R&D Officer | - |
| ELI LILLY AND COMPANY | Chief Tech/Sci/R&D Officer | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Boston University
Boston University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Covaris LLC
Covaris LLC Medical SpecialtiesHealth Technology Develops, manufactures and markets instruments, consumables & reagents | Health Technology |
FibroBiologics, Inc.
FibroBiologics, Inc. BiotechnologyHealth Technology Develops and commercializes fibroblast-based cell therapies | Health Technology |
Select your edition
All financial news and data tailored to specific country editions